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Hyphema. Part II. Diagnosis and Treatment
Abstract
The clinical appearance of hyphema is variable and is influenced by the volume of blood and the amount
of time erythrocytes are present in the anterior chamber. When hyphema is evident, a complete history
should be obtained and a thorough physical examination performed to direct the initial selection of
diagnostic tests. Secondary complications of hyphema include glaucoma, synechiae, cataract formation,
blood-staining of the cornea, and blindness. Frequent measurement of intraocular pressure is
recommended. The two primary management issues in animals with hyphema are prevention of
secondary hemorrhage (by treating the underlying disease) and control of secondary glaucoma.
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Hyphema. Part II.
FOCAL POINT
Hyphema is frequently associated
with iridocyclitis and generally
implies severe intraocular or
systemic disease.

KEY FACTS
The prognosis for animals with
hyphema depends in large part
on the identification of underlying
diseases; institution of proper
treatment; and careful , long-term
follow-up, p. 74.
A thorough ophthalmic and
systemic diagnostic evaluation
should be performed when
hyphema is present, p. 75.
The two primary management
issues in animals with hyphema
are preventing secondary
hemorrhage (i.e., rebleeding)
and controlling secondary
glaucoma, 77.
Frequent measurement of
intraocular pressure is required
in patients with hyphema, p. 78.

Diagnosis and Treatment*

Maria E. Kallberg, DVM
Stacy E. Andrew, DVM
ABSTRACT: The clinical appearance of hyphemais variable and is influenced by the volume of
blood and the amount of time erythrocytes are present in the anterior chamber. When hyphe
ma is evident, a complete history should be obtained and a thorough physical examination
performed to direct the initial selection of diagnostic tests. Secondary complications of hyphe
ma include glaucoma, synechiae, cataract formation , blood-staining of the cornea, and blind
ness. Frequent measurement of intraocular pressure is recommended. The two primary man
agement issues in animals with hyphema are prevention of secondary hemorrhage (by
treating the underlying di.sease) and control of secondary glaucoma.

art I of this two-part presentation reviewed the pathophysiologic mecha
nisms that most frequently result in hyphema in animals; this article cov
ers diagnostic and treatment considerations. The prognosis for animals
with hyphema depends on identifYing the underlying cause; initiating prope r
treatment; and careful, long-term follow-up.

P

HISTORY
When hyphema is evident, a complete history should be obtained and a thor~
ough physica.l examination performed to direct the ,i nitial selection of appropriate
diagnostic tests. Recent health and vaccination statlls should also be ascertained.
Trauma or ingestion of toxins (e.g., anticoagulant todenticide) should be consid
ered if an animal has access to the outdoors regardless of whether a traumatic in
cident or rodenticide ingestion was witnessed by the owner. Living in or travel to
regiom in which enzootic infectious disease (e.g., ehrlichiosis, Rocky Mountain
spotted fever) is common should alert clinicians to consider infectious agents as a
potential cause of hyphema. Recent drug administration or past illness may be
important factors in determining the cause of hyphema. A recent history of ab
normal vision or behavior before the onset of hyp hema may signifY preexisting or
underlying ocular (e .g., iridocyclitis , glaucoma, retinal detachment) or central
nervous system (e.g., hemorrhage, retrobu1bar optic neuriris) disease. Hisrory of
*Parr I of this [Wo-parr presentation appeared in the November 1999 (Vol. 21 >No . 11 )
issue of Compendium.
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recurrent hyphema is suggestive
of a persistent ocular or system
ic disease.
The time at which hyphema
is first observed may also assist
clinicians in developing a list of
differential considerations. For
example, hyphema from anti
coagulant rodenticide toxicity
takes 5 to 7 days to develop,
whereas hemorrhage occurs im
mediately in patients with ocu
lar trauma. Ocular neoplasia may Figure 1A
also cause an acute onset of hy
phema.

detailed ophthalmic examina
tion of both the anterior and
posterior segments of the af
fected and contralateral eye. In
direct pupillary light response
allows the evaluation of retinal
function, even with a blood
filled anterior chamber, as long
as the contralateral pupil is vis
ible. Iridocyclitis manifests as
conjunctivitis, corneal edema,
miosis, and hyporony. Glauco
ma and retinal detachment are
generally associated with a my
driatic pupil. When hyphema
2
is aruibutable to a systemic dis
3
PHYSICAL EXAMINATION
ease process, the contralateral
The physical examination of
eye may also have clinical sigll:s
an animal with hyphema should
suggestive of the disease. Fun
1
not be limited only ro the affect
duscopic examination allows
ed eye. \Vhen trauma has been
direct visualization of delicate
eliminated as a likely cause, the
vascular structures (retinal and
prudent approach is ro assume
choroidal vasculature) and cen
tral nervous tissue (optic nerve
that a serious sight-threatening
head, retina). Ocular signs sug
ocular disease or life-rhreaten
ing systemic disease is present
gestive of systemic vasculitis are
frequently detected during ex
until proven otherwise. A thor- Figure 1B
ough and detailed physical ex Figure 1-Photograph (A) and photomicrograph (B) amination of the fundus.
amination is indicated to de showing inrrastromal hemorrhage of rhe iris (1) in a
Depending on the cause and
tect any underlying evidence of dog (cornea (2J, anterior chamber (3J, posrerior cham severity of blood-ocular barrier
systemic disease. Petechial hem ber (4j). (Hematoxylin & eosin srain; original magni breakdown and the presence of
orrhages of the mucous mem ficarion, x40)
iridocyclitis, aqueous flare (pre
branes (i.e., conjunctiva, oral
dominantly proteins), hypopy
mucosa, preputial/vulvar m uco
on, or hyphema may appear in
sa) or skin are frequently pre
the anterior chamber. The clin
sent along with thrombocy
ical appearance of hyphema is
topenia or thrombocytopathy.
influenced by the volume of
Intrastromal hemorrhage of the
erythrocytes in the anterior
iris may also be present before
chamber and by how long they
have been present and may dif
hyphema occurs (Figure 1).
Abdominal and thoracic palpa
fer substantially from case to
tion and auscultation may re
case. The term complete or to
tal h),phema is used to describe
veal physical signs suggestive of
hemorrhage filling the entire
a third-compartment hemoranterior chamber and is usually
rhage or vital organ involve- Figure 2-Complere (toral) hyphema in a dog.
memo Unless trauma is defmia result of acute fulminant or
recurrent hemorrhage (Figure 2).
tively identified as the cause of
intraocular hemorrhage, every cat with hyphema
Complete hyphema obstructs the examiner's ability to
visualize intraocular structures.
should have its arterial blood pressure measured to
identify systemic hyperrension. 1
The blood in a complete hyphema may change color
from red to black as a result of altered aqueous dynam
OPHTHALMIC EXAMINATION
ics, indicating the cessation of aqueous circulation. 2 If
hemorrhage was initially minimal and transitory, hyThe physical examination should always include a

IRIDOCYC LlTI S

FUNDUSCOPIC EXAMINATION .

COMPLETE HYPHEMA
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phema is light red in appear
currently (e.g., bone-marrow dis
ease). If bone-marrow disease is
ance. This type of hyphema may
develop a shallow line of demar
suspected based on CBC results,
cation (i.e. , gravity line) when
aspiration cytology with or with
erythrocytes settle due to gravity
out core biopsy is indicated. 4
in a homogeneous layer in the
Serum biochemical profile and
ventral anterior chamber (Figure
urinalysis may help identify such
underlying abnormalities as liver
3). Extensive or persistent hem
orrhageinto the anterior cham
disease, renal insufficiency, or hy
ber appears bright red in color
peradrenocorticism.
and may occlude both the pupil
Indications for selecting more
and iris. Complete hyphema at
specific diagnostic tests are de
tributable to transient hemor
termined by history, physical exrhage that has been present for
3.mination findings, and initial
at least 5 to 7 days appears dark
diagnostic test results. Evalua
red or bluish-black and is re
tion for infectious diseases should
ferred to as eight-baff hyphema Figure 3-Hyphema wirh gravity line. Eryrhrocytes be performed if suggested by ge
(Figure 4) ..1 Decreased oxygena sertle due (0 gravity in a homogeneous layer in rhe ographic location, travel history,
or exposure to other risk factors.
tion of erythrocytes in the ante ventral anterior chamber.
rior chamber is reflected by the
Toxoplasma gondii, feline leukemia
dark color. 2 Chronic active hy
virus (FeLV), feline immuno
phema may appear light or dark
deficiency virus (FIV), and FIP
red or bluish-black, depending
infection and possibly systemic
on when the last active hemor
fungal diseases should be consid
ered when hyphema is evident ,in
rhage occurred. Occlusion of the
a cat. 5 The seroprevalence of T
pupil by hyphema may cause a
relative pupillary block that in
gondii in cats with iridocyclitis
was reported to be as high as
hibits aqueous circulation to the
78.5%. 5 However, serologic evi
anterior chamber, resulting in
subsequent elevated intraocular
dence of infection by T gondii,
pressure (lOP).
FeLV, FIV, or FIP does not nec
There are definitive circum Figure 4-Dark red or bluish-black appearance of essarily correlate with clinical
stances thac determine when eighr-ball hyphema.
disease induced by these causa
blood in the anterior chamber --------------------------------------- rive agents. ' When a systemic
mayor may not clot. Hyphema
bleeding disorder is suspected, a
coagulat,i on profile should be completed. 4
caused by trauma, vasculitis (e.g., feline infectious peri
Sampling of aqueous humor to determine local in
tonitis [FIP]), or iridocycliris may clot, whereas hyphe
traocular antibody production is not ,i ndicated in pa
rna attributable to immune-mediated thrombocytope
tients with hyphema because the sample will be con
nia or warfarin toxicity generally will not dot. '!
Hyphema attributable to rubeosis iridis (new vascular
taminated with systemic blood. When hyphema
proliferation of the iris), intraocular neoplasia, or con
prevents visualization of intraocular structures,
genital ocular anomalies may occasionally clot. "
transcorneal B-mode ultrasound (7.5- to 12-MHz
transducer) is indicated to determine whether retinal
EXPANDED DATABASE
detachment or intraocular tumors are present or to
identify other oCLIlar lesions (e.g., luxated lens, intraoc
Laboratory tests should be performed based on find
ings from the history and physical examination. A di
ular foreign body).G Skull radiographs, computed to
rect blood smear permits rapid estimation of platelet
mography, or magnetic resonance imaging may also re
veal an intraocular foreign body, depending on the
and megathrombocyte numbers and the detection of
erythrocyte and leukocyte involvement (e.g., presence
type or composite. When a metallic intraocular foreign
of schistocyrosis or Haemobartonella). Platelets, leuko
body is suspected, magnetic resonance imaging should
cytes, and erythrocytes should be evaluated by a com
be avoided and computed tomography performed.
plete blood count (CBC); the three cell lines may be af
Retinal function can be evaluated using electroretinog
raphy. 7
fected individually (e.g., thrombocytopenia) or con-
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TREATMENT
Primary management issues in animals with hyphe
rna include preventing secondary hemorrhage (i.e., re
bleeding) by (1) treating the underlying disease, (2)
treating iridocyclitis, and (3) controlling secondary
glaucoma (Table I). There is considerable variation
among specific treatment regimens to eliminate blood
from the anterior chamber, bur the hallmark of hyphe

rna treatment is management of the iridocyclitis that is
frequently present. Erythrocytes exit the anterior cham
ber primarily through the iridocorneal dra,i nage angle.
The iris produces enough fibrinolytic enzymes in most
instances to prevent blood from cloning so that it can
more easily exit the anterior chamber via the aqueous
humor outflow pathways. Uncomplicated hyphema
should resolve within 7 to 21 days. 3 Hyphema that

TABLE I
Treatment of Hyphema".I

J

Disorder
Iridocyclitis)'

Drug Class

Drug

Frequency/Dose

Topical parasympatholytics

Atropine 1% (use ointment
in cats)

1-4 times daily

Topical corticosteroids

Prednisolone acetate suspension
1%, dexamethasone solution 0.1 %

4-6 times daily

Dexamethasone ointment 0.05%

3-4 times daily

Flurbiprofen 0.03%, suprofen 1%,
indomethacin 1%, diclofenac 0.1 %

4 times daily

Prednisone

1-2 mg/kg/day in
divided doses

Aspirin

Dogs: 10-15 mg/kg PO
2-3 times daily
Cats: 80 mg PO every
48-72 hr

Flunixin meglumine

Dogs: 0.25-0.5 mg/kg
IV, single dose

Carprofen

Dogs: 2 mg/kg PO
t\vice daily

Topical NSAIDs
y temic corticosteroids
Systemic NSAIDs

Blood or fibrin clot \9

Fibrinolytics

Tissue plasminogen activator

25-75 flg intracamerally

Secondary glaucoma ' O. 11

Systemic carbonic
anhydrase inhibitors

Dichlorphenamide

Dogs: 2-4 mg/ kg PO
2-3 times daily
Cats: 1 mg/kg PO 2-3
times daily

Methazolamide

2-4 mg/kg PO 2-3
times daily

Topical carbonic
anhydrase inhibitors

Do rzolamide 3%

3 times daily

Topical sympathomimetic
drugs

Epinephrine 1%,
di pivefrin HCI 0.1 %

2-3 times daily

Topical sympatholytic
drugs
Osmotic agents

T imolol maleate 0. 5%

2-3 times daily

Mannitol

0.5-1.0 g/kg IV

"See rexr for derails.

"Underlying diseases should be rreared firsr in cases ofhyphema.
IV = inrravenously; PO = orally.
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continues to bleed may indicate that the underlying
disease is still present. Surgical removal of a blood clot
with or without iridectomy is discussed in the human
medicalliterature 2• 12 and is rarely necessary in human or
veterinary patients.
Prevention of a posterior synechiae and iris bombe is
achieved with the use of topical parasympatholytics
(e.g., atropine) to dilate the pupil and topical cortico
steroids to suppress anrerior uveitis (Table I). In addi
tion to prevenring synechiae, topical atropine (a topical
mydriatic and cycloplegic drug) also relieves some pain
associated with spasm of the ciliary musculature and
helps to stabilize the blood-aqueous barrier. I.I- 1> If an
increase in lOP is noted after the initiation of mydriat
ic treatment, atropine should be discontinued immedi
ately and glaucoma treatment initiated.'
Topical use of parasympathomimetic drugs (e.g., pi
locarpine) to treat hyphema has been advocated to con
tract the ciliary musde, which hypothetically facilitates
drainage of blood from the anrerior chamber through
the iridocorneal angle. I !; Parasympathomimetic drugs
also cause miosis, which increases iris surface area,
thereby hypothetically exposing iris surface fibri
nolysins to the clot and blood in the anrerior cham
ber. 1(. We do not recommend using topical parasympa
thomimetic drugs to treat hyphema; they dilate iris
blood vessels and increase iridal intravascular pressure,
which may exacerbate hyphema. Because these drugs
induce miosis, the risk of posterior synechiae forma
tion, iris bombe, and peripheral anrerior synechiae for
mation is increased.
Nonspecific reduction of ocular inflammation to pre
serve the transparency and function of ocular structures
and stabilize the blood-aqueous barrier can be achieved
with topical corticosteroids andlor NSAIDs (Table
I). Ll.1 7 Topical corticosteroids are contraindicated when
corneal ulceration is present. Systemic administration
of NSAIDs can further decrease inflammation but
should also be used very cautiously because of their in
terference with platelet function. Systemic cortico
steroids (e.g., prednisone, prednisolone) should be used
cautiously and only when systemic infectious disease
has been ruled out or is being treated concurrently. Sys
temic immunosuppressive doses of corticosteroids and
systemic carbonic anhydrase inhibitors may help to
reattach retinas in patients w·i th exudative detach
ments. IH.l~
Although the use of anrifibrinolytic agents in the
managemenr of hyphema is conrroversial, intracameral
injection of tissue plasminogen activator (tPA) to in
duce fibrinolysis can be performed to reverse a pupil
lary block when the iris is adhered to the lens by a
blood or fibrin clot (Table I) ..1.~. 12 tPA is most effective

PARASYMPATHOMIMETIC DRUGS

when injected within 48 hours of clot formation, but it
can also be effective tn dissolving clots of longer dura
tion. ' However, tPA injections may also induce hyphe
rna or result in more severe hyphema from dissolution
of a blood clot when given within 24 hours of the ini
tial hemorrhage or when recurrent bleeding is Iikely..1 9
Surgical intervention and concurrent systemic and
topical treatment with antibiotics should be considered
when hyphema results from penetrating ocular injury
or blunt trauma with eyeball rupture. Restricted exer
cise or even cage rest is recommended to prevent re
bleeding. Animals with hyphema may need to be hos
pitalized for close monitoring of possible secondary
hemorrhages and elevation of rOp. lOP should be mea
sured at least daily during the hospital stay a'nd fre
quently after discharge. 12 ,IG We do not recommend
Schiotz tonometry in animals with weakened corneas
caused by penetrating trauma.
If secondary glaucoma develops due to anterior or
posterior synechiae of the iris , treatment can be at
tempted (e.g., intracameral tPA and antiglaucoma
drugs) but the prognosis to save vision is poor. When
the eyeball is irreversibly blind or painful from sec
ondary glaucoma, enucleation should be performed.
Medical treatment of secondary glaucoma consists of a
combination of systemic or topical carbonic anhydrase
inhibitors, topical sympathomimetic drugs, and sympa
tholytic drugs (Table I). Osmotic agents are less effec
tive with a leaky blood-ocular barrier. Because of the
risk of posterior synechiae, parasympathomimetic drugs
(e.g., pilocarpine) are contraindicated.
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COMPLICATIONS

10.

Mild hyphema may resolve without significant se
quelae. The main complications of persistent hyphema
are increased lOP, peripheral anterior and posterior
synechiae, development of cataracts, and an increased
risk of corneal bll ood staining attributable to endothe
lial damage and breaks in Descemet's membrane. 12 If an
underlying disease persists and hemorrhage is recurrent,
atrophy of the eyeball (phthisis bulbi) and blindness are
usually the long-term results.

1.

2.

3.

4.

5.
6.

7.

8.

9,

I 1.

I

12.

I

\3,

14,

PROGNOSIS
Prognosis for vision in geriatric dogs with hyphema
secondary to retinal disease is grave, 20 In cases of unex
plained, unresponsive, or recurring hyphema, the diag
nosis must be reassessed. Prognosis is grave for any hy
phema in which an unknown underlying systemic
disease persists. In such cases, enucleation is recom
mended if the lOP rises to leve'ls that cause pain. When
intraocular neoplasia is known or strongly suspected as
the cause for hyphema, the affected eye should be enu

TISSUE PLASMINOGEN ACTIVATOR .

SURGICAL INTERVENTION

15 .

1

16,

1

17. \

18.

cleared and submiued for histopathologic evaluation. l
If the underlying cause is nonrec urring or treated and
lOP does nor increase, an accurate prognosis for return
of the eye to cosm e tic and visual normalcy can be made
once resorption of the h emorrhage allows a complete
intraocular examination ..' It is difficult to predict wheth
er hyphema will resorb.
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d. all of the above
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